SAC Capital
FT. LAUDERDALE, FL -- (MARKET WIRE) -- 06/22/09 -- LyfeTec, Inc. (PINKSHEETS: TSHL), a publicly traded company currently on the Over the Counter, announces it has signed a letter of intent to acquire Macada Design Group, Inc. -- a world wide apparel entity with a strong driving force that was formed to act as a holding company for three other design corporations which will soon sign agreements to merge. Deanna Hodges will become the CEO of the surviving corporation. We are now in process of filing today with Pinksheet (OTCIQ) all company information ...
In a 13G filing on Sotheby's (NYSE: BID), Timothy Barakett's Atticus Capital LP disclosed a 3,584,110 share, or 5.4% stake. A 13G indicates a 'passive ...
In a 13G filing on Vanda Pharmaceuticals, Inc. (Nasdaq: VNDA), Steven ...
Quiksilver (NYSE: ZQK) 13.5% LOWER; reports Q2 EPS of $0.05, ex-items, 1 cent better than the analyst estimate of $0.04. Revenue for the quarter was $494.2 million, versus the consensus of $502.10 million. Sees Q3 EPS in the low-single digit range. Q3 sales are expected to be down in the mid-teens on a percentage basis compared to the same quarter a year ago.
The Men's Wearhouse (NYSE: MW) 9% HIGHER; reports Q1 EPS of $0.10, versus the analyst estimate of ($0.01). Revenue for the quarter was $464.1 million, versus the consensus of $459.30 million. Same stores sales for the quarter fell 7%. Sees Q2 GAAP EPS of $0.56-$0.60, versus the consensus of $0.. Same store sales of its retail apparel business are expected to decline in a range of 4-6%, while comparable store sales of its tuxedo rental revenues to increase in a range of 3%-5%.
CBL ...
http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=6370356
-
Form SC 13D/A TERRA INDUSTRIES INC Filed by: SAC Capital Advisors LP
-
Form 13F-HR SAC Capital Advisors LP For: Mar 31
-
Form 13F-HR SAC CAPITAL ADVISORS For: Mar 31
-
Steve Cohen SAC Capital Accumulates 5.2% Stake in Terra Industries (TRA), Could Ruffle Feathers
-
Form SC 13D TERRA INDUSTRIES INC Filed by: SAC Capital Advisors LP
-
Wells Fargo Adds Eight Industry Veterans to Equity Research and Equity Sales & Trading Teams
-
LyfeTec, Inc. Announces Its Influenza A/B Test Kit Tests Help Detect Possibility in Swine Flu Infected Patients
-
LyfeTec, Inc. Announces Re-Designation of Medical Test Kit Distribution Rights
-
Form SC 13D/A I2 TECHNOLOGIES INC Filed by: SAC Capital Advisors LP
-
Steve Cohen Is Not Only Buying Art From Sotheby's (BID), Now He Owns a 5.9% Stake In the Stock
-
Who is Ron Insana Going To Bump On CNBC?
-
Cohen's SAC Capital Discloses New 5% Stake in InterMune (ITNM)
-
Ron Insana Strikes Out At SAC Capital
-
Top 15 For 2008 (No. 6): Hedge Fund Meltdown
-
SAC Capital To Allow Some Early Redemptions
-
Quarterly Data Confirms Hedge Funds Exited Stocks In A Big Way
-
SAC Capital Cuts Staff
-
Could The Porsche-Volkswagen Squeeze Cause Some Hedge Funds To Go Bankrupt?
-
Some Hedge Funds Still Raising Money-SAC, Greenlight, Elliott Mgmt & Brevan Howard
-
Lahde Capital's Andrew Lahde Calls It Quits And Publishes A Farewell Letter You MUST Read
-
Top 10 News Items 10/13-10/17: Treasury to Directly Buy Up to $250B in Financial Stocks; Volatility Dominates the Markets; Buffett Sticks His Neck Out with 'Buying American. I Am.' Article
-
Cramer Says Bet On SAC's Stevie Cohen
-
Steve Cohen And Other Hedge Fund Titans Shift To Cash Amid Turmoil
-
Cohen's SAC Capital Boosts Stake in United Therapeutics (UTHR) to 7.4%
-
Cohen's SAC Capital Discloses 3% Stake in James River Coal (JRCC)
-
Cohen's SAC Capital Accumulates Stakes in Target (TGT), Pilgrim's Pride (PPC) and Some Financials (STI, FITB, STT)
-
Cohen's SAC Capital Cuts Stake in Invitrogen (IVGN) to 5.3%
-
Ron Insana To Close Up Shop And Head To SAC Capital
-
Cohen's SAC Capital Boosts Stake in Incyte (INCY) to 6.4%
-
Cohen's SAC Capital Raises Stake in Invitrogen (IVGN) from 5.2% to 6.9%
-
Cohen's SAC Capital Cuts Stake in Barrier Therapeutics (BTRX) to 1.21%
-
Who's Talk Was Louder on Lehman (LEH) Today - Bill Gross or Ben Bernanke?
-
SAC Capital Still Trading With Lehman (LEH) - Bloomberg
-
Cohen's SAC Capital Discloses 8% Stake in Barrier Therapeutics (BTRX), Files 13D
-
Cohen's SAC Capital Accumulates 5.1% Stake in Inspire Pharmaceuticals (ISPH)
-
Cohen's SAC Capital Boosts Stake in Akorn (AKRX) to 5.6%
-
Cohen's SAC Capital Discloses 5.2% Stake in Invitrogen (IVGN), Supports Merger With Applera
-
Cohen's SAC Capital Discloses 5% Stake in Navistar (NAV)
-
UPDATE: Cohen's SAC Capital Accumulates 5.3% Stake In Takeover Target Take-Two Interactive (TTWO)
-
Cohen's SAC Capital Files 13D On Take-Two Interactive (TTWO) Showing 5.3% Stake
-
Cohen's SAC Capital Builds 6.1% Stake in Emergency Medical Services (EMS)
-
Cohen's SAC Capital Accumulates 7.1% Stake in Sanderson Farms (SAFM)
-
Cohen's SAC Capital Discloses 7.6% Stake in Pilgrims Pride (PPC)
-
Buy Orient-Express (OEH) on Potential Takeover Target -Barron's
-
Cohen's SAC Capital Boosts Stake in Fresh Del Monte (FDP) to 5.1%.
-
Cohen's SAC Capital Accumulates 6.8% Stake in Cardiome Pharma (CRME)
-
D. E. Shaw Boosts "Active" Stake in Orient-Express Hotels (OEH) to 7.6%
-
Cohen's SAC Capital Discloses Nearly 5% Stake in Willbros Group (WG)
-
Cohen's SAC Capital Boosts Stake in Stewart Enterprises (STEI) to Nearly 6%
-
Has The Fear Factor Made Ethanol Stocks A Bargain? (PEIX, AVR, VSE, GPRE)
